The Deep-Tech Acceleration of Synthetic Biology

<div class="ag87-crtemvc-hsbk"><div class="css-vsf5of"><p class="carina-rte-public-DraftStyleDefault-block"><span style="color: rgb(29,28,29);">Novel technological capabilities enabled by the convergence of biology and nano- and digital technology promise to significantly advance synthetic biology. It’s therefore no surprise that imec, a world-leading deep-tech R&amp;D hub, is eager to add value to this rapidly evolving field. Its ambition is to leverage its 15+ years of health-tech expertise, with technologies such as on-chip microfluidic cell sorters, very-high-throughput computational imaging, single-cell and -molecule sensors, high-density micro-electrode arrays for nucleic acid synthesis and precision transfection, and AI. The remarkable, decade-long success of the semiconductor industry is in large part due to its ecosystem-wide collaboration – especially during the research phase. It’s this experience that inspires imec to reach out to the syn-bio industry for input to guide its efforts and set its tech priorities. With this roundtable at SynBioBeta, imec brings together leading innovators from the synthetic biology ecosystem to discuss what is needed to accelerate the field. What are the missing pieces in the hardware and software stacks? When do they need to be filled in? What are the manufacturing challenges in view of increasing precision, accelerating upscaling, and reducing costs? What sort of collaborations do we need to accomplish all of this? We hope you can join us to help answer these questions and pick up insights from fellow experts.</span></p></div></div>